Ahmedabad-based pharmaceutical company Sunrest Lifescience Ltd plans to raise Rs 10.85 crore through an SME public issue. The company has received approval to launch its public issue on the NSE Emerge Platform. The funds raised will be used for expansion, working capital requirements, and general corporate purposes. The public offering consists of a fresh issue of 12.91 lakh equity shares at a price of Rs 84 per share. Sunrest Lifescience offers a diverse range of healthcare and personal care products.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/KYwZuyj
